Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
Go back to Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 6.10 +0.23 (3.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.87 | 52 Week High | $45.34 | |||
| Open | $5.85 | 52 Week Low | $15.92 | |||
| Day High | $6.17 | P/E | 2.62 | |||
| Day Low | $5.80 | EPS | $2.33 | |||
| Volume | 881,684 | |||||
